Skip to main content
Top
Published in: BMC Geriatrics 1/2018

Open Access 01-12-2018 | Research article

Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction

Authors: Yu-Hsiang Lin, Chen-Pang Hou, Tien-Hsing Chen, Horng-Heng Juang, Phei-Lang Chang, Pei-Shan Yang, Chien-lun Chen, Ke-Hung Tsui

Published in: BMC Geriatrics | Issue 1/2018

Login to get access

Abstract

Background

To evaluate the long-term surgical outcomes of patients with urinary retention (UR) caused by a benign prostatic obstruction (BPO) who underwent transurethral resection of the prostate (TURP), and compare their outcomes with those of patients who received medication without surgical intervention.

Methods

This retrospective cohort study analyzed claims data collected during the period of 1997–2012 from Taiwan’s National Health Insurance Research Database. We examined geriatric adverse events among patients who had received a diagnosis of symptomatic benign prostatic hyperplasia and whom experienced UR, and compared those who received TURP and medication only. Primary outcomes included urinary tract infection (UTI), UR, inguinal hernia, hemorrhoids, stroke, acute myocardial infarction, and bony fracture. We excluded patients who had concomitant prostate cancer, bladder cancer, or a long-term urinary catheter indwelling, as well as those who did not receive α-blocker medication regularly. Those aged <50 or >90 years were also excluded. The enrolled patients were categorized into TURP (n = 1218) and medication only (n = 795) groups. After 1:1 propensity score matching, we recorded and compared patients’ characteristics, postoperative clinical outcomes, and geriatric adverse events.

Results

The TURP cohort had a lower incidence of UTI and UR during the postoperative follow-up period from 2 months to 3 years than did the medication only group (20.7% vs. 28.9% and 12.5% vs. 27.6%, respectively, p < 0.001). The life-long bone fracture incidence was also lower in the TURP cohort (7.9% vs. 9.2%, p = 0.048). The incidence of other outcomes during the postoperative follow-up period did not differ between the two groups.

Conclusions

Compared with conservative treatment, TURP provides more favorable clinical outcomes in patients with UR caused by BPO. Patients who underwent TURP had a lower risk of UTI, repeat UR episodes, and emergent bony fracture. Thus, early surgical intervention should be considered for such patients.
Literature
1.
go back to reference Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MCJM. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the triumph project. Eur Urol. 2002;42:323–8.CrossRefPubMed Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MCJM. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the triumph project. Eur Urol. 2002;42:323–8.CrossRefPubMed
2.
go back to reference Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173:1309–13.CrossRefPubMed Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173:1309–13.CrossRefPubMed
3.
go back to reference Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241–6.CrossRefPubMed Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241–6.CrossRefPubMed
4.
go back to reference Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–7.CrossRefPubMed Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–7.CrossRefPubMed
5.
go back to reference Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):643–50. Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):643–50.
6.
go back to reference Pickard R, Emberton M, Neal DE. The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol. 1998;81:712–20.CrossRefPubMed Pickard R, Emberton M, Neal DE. The management of men with acute urinary retention. National Prostatectomy Audit Steering Group. Br J Urol. 1998;81:712–20.CrossRefPubMed
7.
go back to reference Emberton M, Neal DE, Black N, et al. The National Prostatectomy Audit: the clinical management of patients during hospital admission. Br J Urol. 1995;75:301–16.CrossRefPubMed Emberton M, Neal DE, Black N, et al. The National Prostatectomy Audit: the clinical management of patients during hospital admission. Br J Urol. 1995;75:301–16.CrossRefPubMed
8.
go back to reference Davidian MH. Guidelines for the treatment of benign prostatic hyperplasia. US Pharm. 2016;41:36–40. Davidian MH. Guidelines for the treatment of benign prostatic hyperplasia. US Pharm. 2016;41:36–40.
9.
go back to reference Ghalayini IF, Al-Ghazo MA, Pickard RS. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int. 2005;96:93–7.CrossRefPubMed Ghalayini IF, Al-Ghazo MA, Pickard RS. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int. 2005;96:93–7.CrossRefPubMed
10.
go back to reference Gujral S, Abrams P, Donovan JL, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol. 2000;164:59–64.CrossRefPubMed Gujral S, Abrams P, Donovan JL, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol. 2000;164:59–64.CrossRefPubMed
11.
go back to reference Desgrandchamps F, De La Taille A, DOUBLET JD. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. BJU Int. 2006;97:727–33.CrossRefPubMed Desgrandchamps F, De La Taille A, DOUBLET JD. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. BJU Int. 2006;97:727–33.CrossRefPubMed
12.
go back to reference Hsiao F, Yang C, Huang Y, Huang W. Using Taiwan’s national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal. 2007;15(2):99. Hsiao F, Yang C, Huang Y, Huang W. Using Taiwan’s national health insurance research databases for pharmacoepidemiology research. J Food Drug Anal. 2007;15(2):99.
13.
go back to reference Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.CrossRefPubMed
14.
go back to reference Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474.CrossRefPubMed Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474.CrossRefPubMed
15.
go back to reference Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate. 1996;29:67–73.CrossRef Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate. 1996;29:67–73.CrossRef
16.
go back to reference Walsh PC. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. J Urol. 1995;154:301.PubMed Walsh PC. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. J Urol. 1995;154:301.PubMed
17.
go back to reference Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–7.CrossRefPubMed Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158:481–7.CrossRefPubMed
18.
go back to reference Groves HK, Chang D, Palazzi K, Cohen S, Parsons JK. The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer Prostatic Dis. 2013;16:260–5.CrossRefPubMed Groves HK, Chang D, Palazzi K, Cohen S, Parsons JK. The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer Prostatic Dis. 2013;16:260–5.CrossRefPubMed
19.
go back to reference Lieber MM, Rhodes T, Jacobson DJ, McGree ME, Girman CJ, Jacobsen SJ, et al. Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times. BJU Int. 2010;105(2):214–9. Lieber MM, Rhodes T, Jacobson DJ, McGree ME, Girman CJ, Jacobsen SJ, et al. Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times. BJU Int. 2010;105(2):214–9.
21.
go back to reference Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001;19:591.CrossRefPubMed Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001;19:591.CrossRefPubMed
22.
go back to reference Murray K, Massey A, Feneley RC. Acute urinary retention--a urodynamic assessment. Br J Urol. 1984;56:468.CrossRefPubMed Murray K, Massey A, Feneley RC. Acute urinary retention--a urodynamic assessment. Br J Urol. 1984;56:468.CrossRefPubMed
23.
go back to reference Khan M, Khan AL, Khan AS, Nawaz H. Benign prostatic hyperplasia: mode of presentation and postoperative outcome. J Pak Med Assoc. 2005;55:20–3.PubMed Khan M, Khan AL, Khan AS, Nawaz H. Benign prostatic hyperplasia: mode of presentation and postoperative outcome. J Pak Med Assoc. 2005;55:20–3.PubMed
24.
go back to reference Hallett JM, Stewart GD, McNeill SA. The Management of Acute Urinary Retention: treating the curse of the aging male. Curr Bladder Dysfunct Rep. 2013;8:242–9.CrossRef Hallett JM, Stewart GD, McNeill SA. The Management of Acute Urinary Retention: treating the curse of the aging male. Curr Bladder Dysfunct Rep. 2013;8:242–9.CrossRef
25.
26.
go back to reference Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N’Dow J, Nordling J, Jean J. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118–40.CrossRefPubMed Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N’Dow J, Nordling J, Jean J. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118–40.CrossRefPubMed
27.
go back to reference Fusco F, Palmieri A, Ficarra V, Giannarini G, Novara G, Longo N, Verze P, Creta M, Mirone V. α1-blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies. Eur Urol. 2016;69:1091–101.CrossRefPubMed Fusco F, Palmieri A, Ficarra V, Giannarini G, Novara G, Longo N, Verze P, Creta M, Mirone V. α1-blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies. Eur Urol. 2016;69:1091–101.CrossRefPubMed
28.
go back to reference Hagiwara K, Koie T, Iwamura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. Efficacy and safety of Silodosin and Dutasteride combination therapy in acute urinary retention due to benign prostatic hyperplasia: a single-arm prospective study. Biomed Res Int. 2016;2016:4975851. https://doi.org/10.1155/2016/4975851. Epub 2016 Apr 18. Hagiwara K, Koie T, Iwamura H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C. Efficacy and safety of Silodosin and Dutasteride combination therapy in acute urinary retention due to benign prostatic hyperplasia: a single-arm prospective study. Biomed Res Int. 2016;2016:4975851. https://​doi.​org/​10.​1155/​2016/​4975851. Epub 2016 Apr 18.
29.
go back to reference Lucas MG, Stephenson TP, Nargund V. Tamsulosin in the management of acute urinary retention from benign prostatic hyperplasia. BJU Int. 2005;95(3):354–7.CrossRefPubMed Lucas MG, Stephenson TP, Nargund V. Tamsulosin in the management of acute urinary retention from benign prostatic hyperplasia. BJU Int. 2005;95(3):354–7.CrossRefPubMed
30.
go back to reference Rosenbaum PR, Donald BR. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.CrossRef Rosenbaum PR, Donald BR. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.CrossRef
31.
go back to reference Perchon LF, Pintarelli VL, Bezerra E, Thiel M, Dambros M. Quality of life in elderly men with aging symptoms and lower urinary tract symptoms (LUTS). Neurourol Urodyn. 2011;30:515–9.CrossRefPubMed Perchon LF, Pintarelli VL, Bezerra E, Thiel M, Dambros M. Quality of life in elderly men with aging symptoms and lower urinary tract symptoms (LUTS). Neurourol Urodyn. 2011;30:515–9.CrossRefPubMed
33.
go back to reference Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Tsui KH. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide population-based cohort study. Clin Interv Aging. 2017;12:535.CrossRefPubMedPubMedCentral Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Tsui KH. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide population-based cohort study. Clin Interv Aging. 2017;12:535.CrossRefPubMedPubMedCentral
34.
go back to reference Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10:540–8.CrossRefPubMed Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10:540–8.CrossRefPubMed
35.
go back to reference Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, Marshall LM. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;104:63–8.CrossRefPubMedPubMedCentral Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, Marshall LM. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;104:63–8.CrossRefPubMedPubMedCentral
36.
go back to reference Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, Tsuji I. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413–8.CrossRefPubMed Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, Tsuji I. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413–8.CrossRefPubMed
37.
go back to reference Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84:297–301.CrossRefPubMed Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84:297–301.CrossRefPubMed
38.
go back to reference Ooi WL, Hossain M, Lipsitz LA. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med. 2000;2:106–11.CrossRef Ooi WL, Hossain M, Lipsitz LA. The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med. 2000;2:106–11.CrossRef
39.
go back to reference Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Lotan Y. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41.CrossRefPubMed Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Lotan Y. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63:234–41.CrossRefPubMed
40.
go back to reference Lee WC, Lin YH, Hou CP, et al. Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging. 2013;8:1483–8.PubMedPubMedCentral Lee WC, Lin YH, Hou CP, et al. Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging. 2013;8:1483–8.PubMedPubMedCentral
Metadata
Title
Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction
Authors
Yu-Hsiang Lin
Chen-Pang Hou
Tien-Hsing Chen
Horng-Heng Juang
Phei-Lang Chang
Pei-Shan Yang
Chien-lun Chen
Ke-Hung Tsui
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2018
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-018-0709-3

Other articles of this Issue 1/2018

BMC Geriatrics 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.